van Oosterhout, M., Levarht, E., Sont, J., Huizinga, T., Toes, R., & van Laar, J. M. (2005). Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNFα and IL18 but not CXCL12.

van Oosterhout, M., E. Levarht, J. Sont, T. Huizinga, R. Toes, a J M. van Laar. Clinical Efficacy of Infliximab Plus Methotrexate in DMARD Naive and DMARD Refractory Rheumatoid Arthritis Is Associated With Decreased Synovial Expression of TNFα and IL18 but Not CXCL12. 2005.

van Oosterhout, M., et al. Clinical Efficacy of Infliximab Plus Methotrexate in DMARD Naive and DMARD Refractory Rheumatoid Arthritis Is Associated With Decreased Synovial Expression of TNFα and IL18 but Not CXCL12. 2005.